483 related articles for article (PubMed ID: 4213330)
1. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
[No Abstract] [Full Text] [Related]
2. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
3. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
Hoiby N
Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
[No Abstract] [Full Text] [Related]
4. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
Hoiby N; Flensborg EW; Beck B; Friis B; Jacobsen SV; Jacobsen L
Scand J Respir Dis; 1977 Apr; 58(2):65-79. PubMed ID: 404701
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
Holby N
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.
Høiby N; Wiik A
Scand J Respir Dis; 1975 May; 56(1):38-46. PubMed ID: 238280
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
McIsaac SM; Stadnyk AW; Lin TJ
J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
11. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa and cystic fibrosis: intrastrain variability in relation to intensity of immune response and clinical outcome.
Quentin R; Bollet C; Dayan A; Martin C; Goudeau A; De Micco P
New Microbiol; 1993 Apr; 16(2):185-8. PubMed ID: 8510574
[TBL] [Abstract][Full Text] [Related]
13. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
14. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
15. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pressler T
APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
[No Abstract] [Full Text] [Related]
16. Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis.
Schiøtz PO
Acta Pathol Microbiol Scand Suppl; 1981; 276():1-25. PubMed ID: 6951389
[No Abstract] [Full Text] [Related]
17. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
[TBL] [Abstract][Full Text] [Related]
18. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
19. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
Marshall BC; Carroll KC
Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
[TBL] [Abstract][Full Text] [Related]
20. [Anti-pseudomonas-specific precipitins as a marker of chronic infection in patients with cystic fibrosis].
Castello D; Mari C; Visca A
Minerva Pediatr; 1999 Mar; 51(3):47-51. PubMed ID: 10368566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]